A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients

NCT05335265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2022-04-28

No results posted yet for this study

Summary

According to the World Health Organization data, the third most common cause of death in the world, is COPD , a disease that progresses with exacerbations (1). Exacerbations are the most important cause of morbidity and mortality in COPD (2). It is thought that most exacerbations occur (3,4) because highly effective inhaler treatments are unavailable to prevent and treat respiratory symptoms (5,6). However, using inhaler devices correctly can be difficult (jama7,8). Guidelines recommend evaluating and teaching inhaler use technique (5,6). Unfortunately, these are often not implemented, especially in a hospital setting (9,10). Worldwide, 25 billion dollars are spent annually on inhaler drugs, 5-7 billion dollars of which is estimated to be wasted because of incorrect technique. Beyond this financial cost, incorrect inhaler technique is associated with worse symptom control, lower quality of life and increased acute care costs, (11,12,13). Although these shortcomings are known, appropriate educational interventions are unfortunately not been available.

Additionally , patient's access to health services (especially face-to-face communication with recommended health providers) has been largely prevented due to the restrictions/requirements implemented against the pandemic in 2020,such as social isolation, staying away from public environments, and ensuring good personal and social hygiene.

Considering that inhaler training is done face-to-face by doctors or allied health personnel today, many patients did not receive inhaler drug use training. One of the most realistic solutions that we encountered with this pandemic is telemedicine. The use of internet-mediated training, which is a part of telemedicine, has come to the foreground. In a recently published study on chronic airway diseases (asthma and COPD), it was revealed that video-mediated inhaler training is as successful as classical face-to-face training (14).Our aim is to investigate whether video-mediated virtual inhaler training is successful in patients with COPD.

Conditions

  • COPD
  • Inhaler Training
  • Face-to-face Training
  • Video-mediated Virtual Training

Interventions

OTHER

Treatment training

Face-to-face:Metered-DoseInhalerTraining gave 3 times on the 1st day, 2 times on the 2nd day, once on the 3rd day.During discharge, inhaler technical evaluation were done according to the "Application Steps of Inhalation Techniques Evaluation Form checklist" prepared by using the Patient's Booklet of the Turkish Thoracic Society (TTS).The people who is evaluate the patient's inhaler technique (IT) on the day of discharge was someone different from the health personnel who provided the training. In IT control, the patient's performance was evaluated simultaneously by 2 observers. Video training:Training gave 3 times on the 1st day, 2 times on the 2nd day,once on the 3rd day.The TTS-Virtual Training Video were used.During discharge,inhaler technical evaluation was done same with face-to-face training.The person who is evaluate the patient's IT was someone different from the training personnel.In IT observation,it was used same method with face-to-face training.

Sponsors & Collaborators

  • Ayse Baha

    lead OTHER

Principal Investigators

  • Ayse Baha · Near East University Faculty of Medicine

  • Dilek Yapar · Antalya Muratpasa District Health Directorate

  • Aylin O Alpaydin · Dokuz Eylül University Faculty of Medicine

  • Aycan Yuksel · Ufuk University

  • Ayshan Mammadova · Gazi University Faculty of Medicine

  • Ali Uzan · Near East University Faculty of Medicine

  • Deniz Kizilirmak · Celal Bayar University Faculty of Medicine

  • Esen S Gulensoy · Ufuk University

  • İlknur Kaya · Kütahya Faculty of Health Science

  • Irem Serifoglu · Ankara City Hospital Bilkent

  • Ismail Zehir · Kütahya Faculty of Science

  • Merve Y Senel · Balıkesir State Hospital

  • Nalan Ogan · Ufuk University

  • Nurdan Kokturk · Gazi University Faculty of Medicine

  • Secil Sari · Celal Bayar University Faculty of Medicine

  • Umran O Sertcelik · Ankara City Hospiatl

  • Zuleyha Galata · Gazi University Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335265 on ClinicalTrials.gov